Haemonetics HAE Income Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| $346.35M+4.8% | $338.97M-2.7% | $327.32M-5.3% | $321.39M-4.4% | $330.6M-3.7% | ||
| $148.14M+7.7% | $136.58M-11.9% | $132.57M-16.1% | $129.15M-19.9% | $137.55M-17.8% | ||
| $198.21M+2.7% | $202.39M+4.6% | $194.74M+3.9% | $192.24M+9.9% | $193.05M+9.7% | ||
| 57.2%-1.2pp | 59.7%+4.2pp | 59.5%+5.2pp | 59.8%+7.8pp | 58.4%+7.2pp | ||
| $14.45M-21.1% | $14.19M-10.4% | $14.87M+5.2% | $16.26M+12.5% | $18.31M+15.4% | ||
| $120.93M+5.0% | $109.15M+2.5% | $101.62M-5.0% | $110.72M+2.3% | $115.14M+5.4% | ||
| $27.32M-3.2% | $27.39M-5.7% | $28.26M-3.3% | $28.76M-1.3% | $28.21M+2.1% | ||
| $221.24M+81.8% | $134.99M+0.4% | $136.25M+0.4% | $138.37M+2.4% | $121.72M-16.6% | ||
| —— | $67.4M+14.2% | $58.49M+13.1% | $53.87M+35.5% | $71.34M+138% | ||
| -$5.37M-799% | -$7.42M+18.6% | -$7.21M-3.0% | -$8.7M-225% | -$598K+90.8% | ||
| —— | $59.98M+20.1% | $51.29M+14.7% | $45.17M-3.3% | $70.74M+202% | ||
| —— | $15.24M+22.6% | $12.6M+15.9% | $11.14M+33.5% | $12.76M+319% | ||
| —— | $44.74M+19.3% | $38.68M+14.3% | $34.03M-11.3% | $57.98M+185% | ||
| —— | $0.95+28.4% | $0.81+22.7% | $0.70-5.4% | $1.17+192% | ||
| —— | $0.96+28.0% | $0.81+22.7% | $0.71-5.3% | $1.17+193% | ||
| 47.4M-6.7% | 47M-7.2% | 47.7M-7.0% | 48.4M-6.2% | 50.7M-1.3% | ||
| 47.2M-6.3% | 46.8M-6.9% | 47.6M-6.5% | 48.1M-5.6% | 50.3M-0.7% | ||
| $10.49M-7.1% | $10.93M-10.6% | $11.18M-8.8% | $11.39M-8.7% | $11.3M+8.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | -$2.06M+14.7% | -$725K+68.8% | -$3.23M+16.1% | —— | ||
| $21.64M+3,520% | $21.64M+3,520% | $21.64M+3,520% | $21.64M+3,520% | $597.75K-77.1% | ||
| —— | -$6.7M— | —— | -$47.9M-8.6% | —— | ||
| $22.24M+315% | -$11.06M-724% | $7.26M-24.2% | -$3.56M+55.4% | -$10.34M— | ||
| -$8.46M-2,425% | -$13.84M-180% | -$21.76M-302% | -$3.3M-109% | $364K-98.1% | ||
| $6.73M— | $4.61M-77.6% | $5.9M+45.7% | $17.79M+80.8% | —— | ||
| -$101.5M— | $0-100% | -$76.55M— | -$2.44M-101% | —— | ||
| -$86.61M— | -$29.47M-69.6% | -$30.47M-30.4% | -$33M+76.3% | —— | ||
| $70.94M-39.1% | $93.56M+114% | $111.32M+128% | $17.4M+163% | $116.56M+81.9% | ||
| -$5.37M-799% | -$7.42M+18.6% | -$7.21M-3.0% | -$8.7M-225% | -$598K+90.8% | ||
| $5.98M+221% | $2.07M-42.3% | $865K-66.7% | $1.81M-5.8% | $1.86M-68.3% | ||
| $100M-33.3% | —— | —— | —— | $150M— | ||
| $0— | $0— | $0— | $0-100% | —— | ||
| $17.66M+12.9% | $6.35M-25.7% | $5.02M-46.8% | $3.75M-33.6% | $15.64M+134% | ||
| -$13K+51.9% | -$14K+90.6% | -$39K-255% | -$36K+41.9% | -$27K+75.0% | ||
| $526K-78.5% | $432K+72.1% | $120K-81.6% | $297K-98.5% | $2.45M+345% | ||
| —— | $1.15M+127% | $63K-74.9% | $462K-51.9% | —— | ||
| —— | $1.56M+0.1% | $1.56M— | $1.56M0.0% | $1.56M-55.3% | ||
| —— | $338.97M-2.7% | $327.32M-5.3% | $321.39M-4.4% | —— | ||
| $9.13M+31.6% | $7.8M-5.1% | $7.59M+10.7% | $9.31M+22.1% | $6.94M-6.5% | ||
| —— | $67.4M+14.2% | $58.49M+13.1% | $53.87M+35.5% | $71.34M+138% | ||
| —— | $94.78M+7.6% | $86.75M+7.2% | $82.63M+19.9% | $99.54M+72.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Haemonetics's profit margins?
- Gross margin is 59.0% and operating margin is 19.0%, with a 13.3% net margin.
- Where does Haemonetics's income statement data come from?
- Every line is extracted from Haemonetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.